A-90 day gavage safety assessment of Boswellia serrata in rats

Toxicology International

Volumn 19, Issue 3, 2012, Pages 273-278

  Singh, Pooja ^a   Chacko, K Mathai ^a   Aggarwal, M L ^a   Bhat, Binu ^a   Khandal, R K ^a   Sultana, Sarwat ^b   Kuruvilla, Binu T ^c  

^a SHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH   (India)

^b HAMDARD UNIVERSITY   (India)

^c Arjuna Natural Extracts Ltd   (India)

Author keywords

Boswellia serrata; NOAEL; Safety; Sub chronic; Toxicity; Wistar rat

Indexed keywords

BOSWELLIA SERRATA EXTRACT; CORN OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BOSWELLIA; BOSWELLIA SERRATA; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; LOW DRUG DOSE; MALE; NONHUMAN; RAT; RISK ASSESSMENT; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALIA; BOSWELLIA SERRATA; RATTUS; RATTUS NORVEGICUS; ZEA MAYS;

EID: 84871316995     PISSN: 09716580     EISSN: 09765131     Source Type: Journal    
DOI: 10.4103/0971-6580.103668     Document Type: Article

References (15)

1. Alternative Medicine Review volume 13, number 2 2008.
2. Singh GB, Atal CK. Pharmacology of an extract of Salai guggal ex-Boswellia serrata, A new non steroidal anti-inflammatory agent. Agents Actions 1986; 18: 407-12.
3. Sharma ML, Bani S, Singh GB. Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int J Immunopharmacol 1989; 11: 647-52.
4. Gupta I, Parihar A, Malhotra P, Gupta S, Ludtke A, Safayhi H, et al. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med 2001; 67: 391-5.
5. Gupta I, Gupta V, Parihar A, Gupta S, Ludtke R, Safayhi H, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: Results of a double-blind, placebo controlled, 6-week clinical study. Eur J Med Res 1998; 3: 511-4.
6. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian medicinal plants. New Delhi: Council of Industrial and Scientific Research; 1956. p. 39.
7. Pandey RS, Singh BK, Yamini B. Tripathi, Extract Of Gum Resins Of Boswellia serrata L. Inhibits Lipopolysaccheriode Induced Nitric Oxide Production In Rat Macrophages Along With Hypolipidemic Property. Indian J Exp Biol 2005; 43: 509-6.
8. Shao Y, Ho CT, Chin CK, Badmaev V, Ma W, Huang MT. Inhibitory activity of Boswellic acids from Bosweliia serrata against human leukemia HL-60 cells in culture. Planta Med 1998; 64: 328-31.
9. Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP. Boswellic acids: Novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 1992; 261: 1143-6.
10. Ammon HP, Safayhi H, Mack T, Sabieraj J. Mechanism of antiinflammatory actions of curcumin and boswellic acids. J Ethnopharmacol 1993; 38: 113-9.
11. Wildfeuer A, Neu IS, Safayhi H, Metzger G, Wehrmann M, Vogel U, et al. Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis. Arzneimittelforschung 1998; 48: 668-74.
12. Safayhi H, Boden SE, Schweizer S, Ammon HP. Concentration-dependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL. Planta Med 2000; 66: 110-3.
13. OECD Guideline (1998). No. 408 for Testing of Chemicals. "Repeated Dose 90 day Oral Toxicity Study in Rodents" adopted on September 21, 1998.
14. WHO. General Guidelines for Methodologies on Research and evaluation of Traditional Medicine. Geneva: WHO; 2000.
15. Safayhi H, Sailer ER, Amnon HPT. 5-lipoxygenase inhibition by acetyl-11-keto-b-boswellic acid. Phytomedicine 1996; 3: 71-2.